CRF Health announced an agreement with EuroQol to launch the EQ-5D web system on its TrialMax Web software platform.
CRF Health, a global provider of eCOA solutions for the life sciences industry, announced an agreement with EuroQol to launch the EQ-5D™ web system on its TrialMax Web® software platform. CRF Health has become the first eCOA provider to be granted permission to host the EQ-5D web version for use in clinical trials. CRF Health can now implement the various EQ-5D products across its set of eCOA software solutions, including TrialMax Touch®, TrialMax Slate® and TrialMax Web®. The EQ-5D was developed as a standardized, non-disease specific instrument for describing and valuing health-related quality of life, generating useful insights into overall changes in health.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.